Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

During the Trading Day
0.798 -0.002 / -0.25%
As of 4:03pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.798 0.00 / 0.00%
 
Volume: 3.6K
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.80
Today’s open0.82
Day’s range0.75 - 0.82
Volume623,722
Average volume (3 months)621,532
Market cap$124.6M
Dividend yield--
Data as of 4:03pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)+31.43%
Earnings growth (this year)+16.67%
Earnings growth (next 5 years)--
Revenue growth (last year)+454.99%
P/E ratioNM
Price/Sales44.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DRRXDURECT Corp0.000.00%
MNOVMediciNova Inc+0.02+0.48%
ECYTEndocyte Inc-0.20-6.62%
CORICorium International...-0.36-6.30%
Data as of 4:00pm ET, 02/08/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$6.3M
Annual profit (last year)-$35.7M
Net profit margin-569.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts

Partner Offers